Navigation Links
HIV drug may slow down metastatic breast cancer, say researchers at Jefferson's Kimmel Cancer Center
Date:6/7/2012

PHILADELPHIAThe HIV drugs known as CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing, researchers from the Kimmel Cancer Center at Jefferson suggest in a preclinical study published in a recent issue of Cancer Research.

Such drugs target the HIV receptor CCR5, which the virus uses to enter and infect host cells, and has historically only been associated with expression in inflammatory cells in the immune system. Researchers have now shown, however, that CCR5 is also expressed in breast cancer cells, and regulates the spread to other tissue.

What's more, blocking the receptor with the CCR5 antagonists Maraviroc and Vicriviroc, two drugs that slow down the spread of the HIV virus by targeting the CCR5 co-receptor of the chemokine CCL5, also prevents migration and spread of breast cancer cells, the researchers found.

"These results are dramatic," said Richard Pestell, M.D., Ph.D., FACP, Director of Jefferson's Kimmel Cancer Center and Chair of the Department of Cancer Biology at Thomas Jefferson University, and study senior author. "Our team showed that the CCR5/CCL5 axis plays a key role in invasiveness, and that a CCR5 antagonist can slow down the invasion of basal breast cancer cells."

"This suggests it may prove to be a viable adjuvant therapy to reduce the risk of metastasis in the basal breast cancer subtype," he added.

Basal tumors, which do not express the androgen or estrogen receptors or HER-2, are typically associated with metastasis and often do not respond to hormonal therapies. Current treatments include chemotherapy, radiation, and surgery, but all demonstrate poor outcomes, thus highlighting the urgent need for a specific targeted therapy for the subtype.

For the study, Dr. Pestell and colleagues investigated the CCL5/CCR5 axis expression in human breast cancer cell lines and the effect of CCR5 antagonists in vitro and in vivo.

An interrogat
'/>"/>

Contact: Steve Graff
stephen.graff@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Response rate high for some patients with metastatic melanoma treated with vemurafenib
2. Rare medical phenomenon of systemic tumor disappearance following local radiation treatment reported in a patient with metastatic melanoma
3. New drug, Vemurafenib, doubles survival of metastatic melanoma patients
4. Balancing oxaliplatin dose with neurological side effects in metastatic colon cancer
5. Researchers identify potential target to delay metastatic pancreatic cancer and prolong survival
6. Moffitt Cancer Center researchers find potential target for treating metastatic cancer
7. Vaccine for metastatic breast, ovarian cancer shows promise
8. Early-stage melanoma tumors contain clues to metastatic potential
9. Mainz University Medical Center deploys new system for therapy of metastatic spinal tumors
10. Targeted agent addition to herceptin has positive effect on metastatic HER-2 breast cancer
11. Combination antibody therapy shows promise in metastatic melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 2014 Alexandria, VA — The ... 10 more communities have joined the growing ranks of ... accreditation. The decisions bring the number of governmental public ... is the non-profit organization that administers the national public ... the health of the public by advancing the quality ...
(Date:9/18/2014)... THURSDAY, Sept. 18, 2014 (HealthDay News) -- Exposure to ... a new study. Hearing different languages in ... and willing to learn from people who are different ... that children, like adults, are often biased against interacting ... them," said Amanda Woodward, a University of Chicago psychology ...
(Date:9/18/2014)... 2014 (HealthDay News) -- Older people become more physically ... the balance of stress hormones during bereavement changes with ... who are grieving are more likely to have weakened ... "During the difficult weeks and months after loss, we ... most abundant type of white blood cell and as ...
(Date:9/18/2014)... September 18, 2014 "Medical staff need ... while also maintaining the patient's privacy," said one of ... this idea in order to supply caregivers with the ... They created a prototype for The Helper to make ... staff to turn patient onto his or her side. ...
(Date:9/18/2014)... Luis Obispo, CA (PRWEB) September 18, 2014 ... Bootie introduced their newest, patent pending bunion splint to ... As one loyalist, Rosa, wrote: "I was absolutely delighted. It ... I honestly forget I am wearing them. THANK YOU FOR ... recently introduced design by saying, "The hole used to slip ...
Breaking Medicine News(10 mins):Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:Study: Exposure to Diversity Might Boost Baby's Social Skills 2Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3
... release of the first long-range plan for tackling digestive ... each year. , Opportunities and Challenges in Digestive Diseases ... describes the impact of diseases ranging from foodborne infections ... for research over the next 10 years. The report ...
... BOTHELL, Wash., April 2 SCOLR Pharma, Inc. ... of HealthPro BioVentures LLC ("HealthPro"), a life sciences ... financial advisor in connection with the evaluation of ... strategic partners."We are excited about HealthPro joining our ...
... may work better than eating less, study finds , , THURSDAY, ... weight, cutting back on the calories in sugar-sweetened drinks, rather ... who found that cutting back on calories from sugary beverages ... nearly two-and-a-half pounds of lost weight over 18 months. ...
... Health Care has appointed a nationally recognized ... president of cancer services. (Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b ... Children,s Research Hospital in Memphis, where he served ... domestic affiliates. Prior to that, he was chief ...
... Medical Systems (NYSE: VAR ) announced today that ... noon through 2 p.m. on May 7, 2009 in Boston ... Lafayette. Management presentations will cover financial performance through the ... opportunities in markets for oncology systems, x-ray imaging, and security ...
... Researchers at UT Southwestern Medical Center have shed ... process important information. , Researchers found in a study ... molecules used by nerve cells to communicate with one ... and changes brain-cell circuitry to process important information differently ...
Cached Medicine News:Health News:NIH releases the first research plan to reduce the burden of digestive diseases 2Health News:NIH releases the first research plan to reduce the burden of digestive diseases 3Health News:SCOLR Pharma, Inc. Announces Engagement of HealthPro as Financial Advisor 2Health News:Fewer Sugary Drinks Key to Weight Loss 2Health News:Fewer Sugary Drinks Key to Weight Loss 3Health News:Nationally Recognized Oncologist to Lead Aurora Health Care's Cancer Services 2Health News:Nationally Recognized Oncologist to Lead Aurora Health Care's Cancer Services 3Health News:Varian Medical Systems Schedules Mid-Year Review With Investors in Boston 2Health News:UT Southwestern researchers reveal how the brain processes important information 2
(Date:9/18/2014)... 19, 2014 ... ) has announced the addition of the ... report to their offering.      ... study of chromosomes using molecular biology to ... and chromosomes. It plays a crucial role ...
(Date:9/18/2014)... September 18, 2014 ... ) has announced the addition of the  ...  report to their offering.       ... worldwide markets for Sugar Alcohols in Million ... & Confectionery, Pharmaceuticals, Cosmetics, Oral-Care Products, and ...
(Date:9/18/2014)... , Sept. 18, 2014   MacPractice,s MacPractice ... Edition Complete EHR certification, which designates that the software ... Stage 1 and Stage 2 Meaningful Use measures required ... Reinvestment Act (ARRA).  MacPractice MD MU version 5.0 was ... , an Office of the National Coordinator-Authorized Certification Body ...
Breaking Medicine Technology:Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3Sugar Alcohols - Global Strategic Business Report 201 2Sugar Alcohols - Global Strategic Business Report 201 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5
... 2, 2011 Doctors should consider using catheterization as ... in diagnosing children with heart defects, according to a ... (Logo: http://photos.prnewswire.com/prnh/20100222/AHSALOGO ) A catheter is ... and used in procedures such as angiography, in which ...
... Lpath, Inc. (OTCBB: LPTN), the category leader ... President and CEO, will present at RetailInvestorConferences.com.DATE: ... EDTLINK: , www.retailinvestorconferences.com >Click the red "register/ ... interactive online event where investors are invited to ...
Cached Medicine Technology:Catheterization Recommended for Treating Pediatric Heart Conditions 2Catheterization Recommended for Treating Pediatric Heart Conditions 3Lpath, Inc. CEO to Present Live, Online at RetailInvestorConferences.com on May 5th 2Lpath, Inc. CEO to Present Live, Online at RetailInvestorConferences.com on May 5th 3
Baby Weitlaner retractor, blunt, 4"....
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
15" overall length, 5" handle....
15" overall length, 9" handle....
Medicine Products: